Cue Biopharma
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $21,942 | $2,149 | $2,954 | $421 |
Gross Profit | 18,736 | 2,069 | 2,954 | 421 |
EBITDA | 3,141 | -7,294 | -7,641 | -11,247 |
EBIT | 1,418 | -7,373 | -8,437 | -12,129 |
Net Income | 1,585 | -7,448 | -8,482 | -12,257 |
Net Change In Cash | 21,942 | 2,149 | 2,954 | 421 |
Free Cash Flow | -1,076 | -9,024 | -3,442 | -8,322 |
Cash | 27,136 | 11,701 | 27,492 | 13,136 |
Basic Shares | 110,512 | 100,869 | 95,459 | 74,254 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $27,466 | $9,287 | $5,490 | $1,245 |
Gross Profit | 23,986 | 9,287 | -32,607 | 1,245 |
EBITDA | -23,041 | -37,528 | -46,052 | -50,491 |
EBIT | -26,521 | -39,878 | -49,488 | -52,297 |
Net Income | -26,602 | -40,674 | -50,733 | -53,010 |
Net Change In Cash | 27,466 | 9,287 | 5,490 | 1,245 |
Cost of Revenue | -12,756 | |||
Free Cash Flow | -21,864 | -36,395 | -39,961 | -41,977 |
Cash | 27,136 | 22,459 | 48,514 | 51,614 |
Basic Shares | 94,731 | 56,328 | 45,754 | 35,649 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.01 |
2025-09-30 | -$0.07 |
2025-06-30 | -$0.09 |
